Ex parte BERG - Page 12




          Appeal No. 93-3114                                                          
          Application 07/825,465                                                      
          teaching to use B-propiolactone-inactivated Fusobacterium                   
          necrophorum bacterin over the use of formaldehyde, heat, and                
          antibiotics deserves and has been granted considerable weight,              
          i.e., the prior art certainly prefers to use formaldehyde to                
          inactivate gram-negative bacteria, we find the evidence as a                
          whole insufficient to support patentability for the full scope              
          of the subject matter claimed.                                              
               Having carefully considered the decision rendered and                  
          supporting opinion in In re Baird, 16 F.3d 951, 8 USPQ2d 1550               
          (Fed. Cir. 1994) in light of the evidence presented in that                 
          case, it is our view that the evidence in this case warrants a              
          different result.  Here, unlike the case in Baird, the prior                
          art expressly states that B-propiolactone may be used to                    
          inactivate gram-negative bacteria and that Fusobacterium                    
          necrophorum is a gram-negative bacterium.  Thus, at the time                
          this application was filed, the claimed process would have                  
          been prima facie obvious to persons having ordinary skill in                
          the art for the specific utility indicated in applicant’s                   
          specification.  Here, the prior art does not indicate why                   
          formaldehyde was preferred.  We will not hazard a guess.                    
          Moreover, here applicant has not compared the activity of B-                


                                       - 12 -                                         





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007